top of page

Is your IND-enabling program strategically ready?
A strategic self-check for IND-bound teams navigating critical nonclinical decisions.
This self-check outlines common elements of IND-enabling toxicology programs. Completion does not equal strategic or regulatory readiness.
The purpose of this checklist is not to validate execution - it is to surface gaps in sequencing, assumptions, and decision ownership before they become regulatory liabilities.
If this self-check raised questions about study alignment, regulatory assumptions, or decision ownership, a Nonclinical Strategy Audit can help bring clarity before regulatory commitments are made.
bottom of page
.png)